Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2012

01-12-2012 | Review Article

Prevalence of drug interactions in hospital healthcare

Authors: María Espinosa-Bosch, Bernardo Santos-Ramos, María Victoria Gil-Navarro, María Dolores Santos-Rubio, Roberto Marín-Gil, Paloma Villacorta-Linaza

Published in: International Journal of Clinical Pharmacy | Issue 6/2012

Login to get access

Abstract

Aim of the review To study the prevalence of drug interactions in hospital healthcare by reviewing literature. Method A review was carried out of studies written in Spanish and English on the prevalence of drug interactions in hospital care published in Pubmed between January 1990 and September 2008. The search strategy combined free text and MeSH terms, using the following keywords: “Drug interaction”, “prevalence” and “hospital”. For each article, we classified independent variables (pathology, age of population, whether patients were hospitalized or not, geographical location, etc.) and dependent variables (number of interactions per 100 patients studied, prevalence of patients with interactions, most common drug interactions, and others). Results The search generated 436 articles. Finally, 47 articles were selected for the study, 3 provided results about drug interactions with real clinical consequences, 42 about potential interactions, and 2 described both. The prevalence of patients with interactions was between 15 and 45 % and the number of interactions per 100 patients was between 37 and 106, depending on the group of studies analyzed. There was a considerable increase in these rates in patients with heart diseases and elderly persons. Conclusion There is a large number of studies on the prevalence of drug interactions in hospitals but they report widely varying results. The prevalence is higher in patients with heart diseases and elderly people.
Literature
1.
go back to reference Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370:185–91.PubMedCrossRef Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370:185–91.PubMedCrossRef
2.
go back to reference Zopf Y, Rabe C, Neubert A, Hahn A, Dormann D. Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf. 2008;31:789–98.PubMedCrossRef Zopf Y, Rabe C, Neubert A, Hahn A, Dormann D. Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf. 2008;31:789–98.PubMedCrossRef
3.
go back to reference Joshua L, Devi P, Guido S. Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2009;18:639–45.PubMedCrossRef Joshua L, Devi P, Guido S. Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2009;18:639–45.PubMedCrossRef
4.
go back to reference Rodríguez-Terol A, Caraballo MO, Palma D, Santos-Ramos D, Molina T, Desongles T, Aguilar A. Calidad estructural de las bases de datos de interacciones. Farm Hosp. 2009;33:134–96.PubMedCrossRef Rodríguez-Terol A, Caraballo MO, Palma D, Santos-Ramos D, Molina T, Desongles T, Aguilar A. Calidad estructural de las bases de datos de interacciones. Farm Hosp. 2009;33:134–96.PubMedCrossRef
5.
go back to reference Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE. Drug related admissions to an Australian hospital. J Clin Pharm Ther. 1994;19:341–7.PubMedCrossRef Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE. Drug related admissions to an Australian hospital. J Clin Pharm Ther. 1994;19:341–7.PubMedCrossRef
6.
go back to reference Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999;54:959–63.PubMedCrossRef Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999;54:959–63.PubMedCrossRef
7.
go back to reference Peyriere H, Cassan S, Floutard E, Riviere S, Blayac JP, Hillaire-Buys D, et al. Adverse drug events associated with hospital admission. Ann Pharmacother. 2003;37:5–11.PubMedCrossRef Peyriere H, Cassan S, Floutard E, Riviere S, Blayac JP, Hillaire-Buys D, et al. Adverse drug events associated with hospital admission. Ann Pharmacother. 2003;37:5–11.PubMedCrossRef
8.
go back to reference Egger T, Dormann H, Ahne G, Runge U, Neubert A, Criegee-Rieck M, et al. Identification of adverse drug reactions in geriatric inpatients using a computerized drug database. Drugs Aging. 2003;20:769–76.PubMedCrossRef Egger T, Dormann H, Ahne G, Runge U, Neubert A, Criegee-Rieck M, et al. Identification of adverse drug reactions in geriatric inpatients using a computerized drug database. Drugs Aging. 2003;20:769–76.PubMedCrossRef
9.
go back to reference Depont F, Vargas F, Dutronc H, Giauque E, Ragnaud JM, Galperine T, et al. Drug-drug interactions with systemic antifungals in clinical practice. Pharmacoepidemiol Drug Saf. 2007;16:1227–33.PubMedCrossRef Depont F, Vargas F, Dutronc H, Giauque E, Ragnaud JM, Galperine T, et al. Drug-drug interactions with systemic antifungals in clinical practice. Pharmacoepidemiol Drug Saf. 2007;16:1227–33.PubMedCrossRef
10.
go back to reference Herr RD, Caravati EM, Tyler LS, Iorg E, Linscott MS. Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med. 1992;21:1331–6.PubMedCrossRef Herr RD, Caravati EM, Tyler LS, Iorg E, Linscott MS. Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med. 1992;21:1331–6.PubMedCrossRef
11.
go back to reference Crespo CA, Guerrero E, Sanmartín P. Interacciones entre medicamentos: detección precoz mediante un sistema computerizado. Farm Hosp. 1992;16:38–44. Crespo CA, Guerrero E, Sanmartín P. Interacciones entre medicamentos: detección precoz mediante un sistema computerizado. Farm Hosp. 1992;16:38–44.
12.
go back to reference Braverman SE, Howard RS, Bryant PR, Belandres PV. Potential drug interactions in a physical medicine and rehabilitation clinic. Am J Phys Med Rehabil. 1996;75:44–9.PubMedCrossRef Braverman SE, Howard RS, Bryant PR, Belandres PV. Potential drug interactions in a physical medicine and rehabilitation clinic. Am J Phys Med Rehabil. 1996;75:44–9.PubMedCrossRef
13.
go back to reference Sierra P, Castillo J, Gomez M, Sorribes V, Monterde J, Castano J. Interacciones potenciales y reales en pacientes críticos. Rev Esp Anestesiol Reanim. 1997;44:383–7.PubMed Sierra P, Castillo J, Gomez M, Sorribes V, Monterde J, Castano J. Interacciones potenciales y reales en pacientes críticos. Rev Esp Anestesiol Reanim. 1997;44:383–7.PubMed
14.
go back to reference Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, Boger RH. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther. 2000;38:504–13.PubMed Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, Boger RH. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther. 2000;38:504–13.PubMed
15.
go back to reference Langdorf MI, Fox JC, Marwah RS, Montague BJ, Hart MM. Physician versus computer knowledge of potential drug interactions in the emergency department. Acad Emerg Med. 2000;7:1321–9.PubMedCrossRef Langdorf MI, Fox JC, Marwah RS, Montague BJ, Hart MM. Physician versus computer knowledge of potential drug interactions in the emergency department. Acad Emerg Med. 2000;7:1321–9.PubMedCrossRef
16.
go back to reference Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38:666–71.PubMedCrossRef Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38:666–71.PubMedCrossRef
17.
go back to reference Mur Lalaguna MA, Cobos Campos R, Hurtado Gomez MF, Marwah RS. Estudio de las interacciones entre fármacos antirretrovirales y tratamiento concominante. Farm Hosp. 2003;27:84–92.PubMed Mur Lalaguna MA, Cobos Campos R, Hurtado Gomez MF, Marwah RS. Estudio de las interacciones entre fármacos antirretrovirales y tratamiento concominante. Farm Hosp. 2003;27:84–92.PubMed
18.
go back to reference Miyasaka LS, Atallah AN. Risk of drug interaction: combination of antidepressants and other drugs. Rev Saude Publica. 2003;37:212–5.PubMedCrossRef Miyasaka LS, Atallah AN. Risk of drug interaction: combination of antidepressants and other drugs. Rev Saude Publica. 2003;37:212–5.PubMedCrossRef
19.
go back to reference Egger SS, Drewe J, Schlienger RG. Potential drug–drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003;58:773–8.PubMed Egger SS, Drewe J, Schlienger RG. Potential drug–drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003;58:773–8.PubMed
20.
go back to reference Wilcock A, Thomas J, Frisby J, Webster M, Keeley V, Finn G, et al. Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre audit. Br J Clin Pharmacol. 2005;60:326–9.PubMedCrossRef Wilcock A, Thomas J, Frisby J, Webster M, Keeley V, Finn G, et al. Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre audit. Br J Clin Pharmacol. 2005;60:326–9.PubMedCrossRef
21.
go back to reference Saltvedt I, Spigset O, Ruths S, Fayers P, Kaasa S, Sletvold O. Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomized study. Eur J Clin Pharmacol. 2005;61:921–8.PubMedCrossRef Saltvedt I, Spigset O, Ruths S, Fayers P, Kaasa S, Sletvold O. Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomized study. Eur J Clin Pharmacol. 2005;61:921–8.PubMedCrossRef
22.
go back to reference Yusuff KB, Balogun O. Physicians’ prescribing of anti-hypertensive combinations in a tertiary care setting in southwestern Nigeria. J Pharm Pharm Sci. 2005;8:235–42.PubMed Yusuff KB, Balogun O. Physicians’ prescribing of anti-hypertensive combinations in a tertiary care setting in southwestern Nigeria. J Pharm Pharm Sci. 2005;8:235–42.PubMed
23.
go back to reference Riechelmann RP, Moreira F, Smaletz O, Saad ED. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol. 2005;56:286–90.PubMedCrossRef Riechelmann RP, Moreira F, Smaletz O, Saad ED. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol. 2005;56:286–90.PubMedCrossRef
24.
go back to reference Glintborg B, Andersen SE, Dalhoff K. Drug-drug interactions among recently hospitalized patients–frequent but mostly clinically insignificant. Eur J Clin Pharmacol. 2005;61:675–81.PubMedCrossRef Glintborg B, Andersen SE, Dalhoff K. Drug-drug interactions among recently hospitalized patients–frequent but mostly clinically insignificant. Eur J Clin Pharmacol. 2005;61:675–81.PubMedCrossRef
25.
go back to reference López Vázquez P, Rodríguez Moreno C, Durán Parrondo C, Tato Herrero F, Rodríguez López I, Lado Lado FL. Interacciones entre medicamentos prescritos al alta en un Servicio de Medicina Interna. An Med Intern. 2005;22:69–75. López Vázquez P, Rodríguez Moreno C, Durán Parrondo C, Tato Herrero F, Rodríguez López I, Lado Lado FL. Interacciones entre medicamentos prescritos al alta en un Servicio de Medicina Interna. An Med Intern. 2005;22:69–75.
26.
go back to reference Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug–drug interactions in patients with heart failure at hospital discharge. Drug Saf. 2006;29:79–90.PubMedCrossRef Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug–drug interactions in patients with heart failure at hospital discharge. Drug Saf. 2006;29:79–90.PubMedCrossRef
27.
go back to reference Hassan FA, Taylor D, Leow F, Doolan G, Knott J. Potential interactions between drugs taken by emergency department patients of an Australian hospital. J Pharm Pract Res. 2006;4:266–70. Hassan FA, Taylor D, Leow F, Doolan G, Knott J. Potential interactions between drugs taken by emergency department patients of an Australian hospital. J Pharm Pract Res. 2006;4:266–70.
28.
go back to reference Hastings SN, Sloane RJ, Goldberg KC, Oddone EZ, Schmader KE. The quality of pharmacotherapy in older veterans discharged from the emergency department or urgent care clinic. J Am Geriatr Soc. 2007;55:1339–48.PubMedCrossRef Hastings SN, Sloane RJ, Goldberg KC, Oddone EZ, Schmader KE. The quality of pharmacotherapy in older veterans discharged from the emergency department or urgent care clinic. J Am Geriatr Soc. 2007;55:1339–48.PubMedCrossRef
29.
go back to reference Miller CD, El-Kholi R, Faragon JJ, Lodise TP. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Pharmacotherapy. 2007;27:1379–86.PubMedCrossRef Miller CD, El-Kholi R, Faragon JJ, Lodise TP. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Pharmacotherapy. 2007;27:1379–86.PubMedCrossRef
30.
go back to reference Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007;99:592–600.PubMedCrossRef Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007;99:592–600.PubMedCrossRef
31.
go back to reference Peral AJ, Lertxundi EU, Martinez Bengoechea MJ, Mora AO, Franco LE, Gabilondo Z. Evaluación prospectiva de interacciones entre medicamentos en pacientes ingresados mediante una aplicación informática. Farm Hosp. 2007;31:93–100.CrossRef Peral AJ, Lertxundi EU, Martinez Bengoechea MJ, Mora AO, Franco LE, Gabilondo Z. Evaluación prospectiva de interacciones entre medicamentos en pacientes ingresados mediante una aplicación informática. Farm Hosp. 2007;31:93–100.CrossRef
32.
go back to reference Radosevic N, Gantumur M, Vlahovic-Palcevski V. Potentially inappropriate prescribing to hospitalised patients. Pharmacoepidemiol Drug Saf. 2008;17:733–7.PubMedCrossRef Radosevic N, Gantumur M, Vlahovic-Palcevski V. Potentially inappropriate prescribing to hospitalised patients. Pharmacoepidemiol Drug Saf. 2008;17:733–7.PubMedCrossRef
33.
go back to reference Blix HS, Viktil KK, Moger TA, Reikvam A. Identification of drug interactions in hospitals–computerized screening vs. bedside recording. J Clin Pharm Ther. 2008;33:131–9.PubMedCrossRef Blix HS, Viktil KK, Moger TA, Reikvam A. Identification of drug interactions in hospitals–computerized screening vs. bedside recording. J Clin Pharm Ther. 2008;33:131–9.PubMedCrossRef
34.
go back to reference Riechelmann RP, Zimmermann C, Chin SN, Wang L, O’Carroll A, Zarinehbaf S, et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage. 2008;35:535–43.PubMedCrossRef Riechelmann RP, Zimmermann C, Chin SN, Wang L, O’Carroll A, Zarinehbaf S, et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage. 2008;35:535–43.PubMedCrossRef
35.
go back to reference Martín I, Feal B, Piñeiro MJ, Cuña B. Detección de interacciones medicamento–medicamento en un sistema de dispensación dosis-día. Farm Hosp. 1992;16:198–202. Martín I, Feal B, Piñeiro MJ, Cuña B. Detección de interacciones medicamento–medicamento en un sistema de dispensación dosis-día. Farm Hosp. 1992;16:198–202.
36.
go back to reference Gonzalez R, Gomez M, Monterde J. Detección “en proceso” de interacciones farmacológicas. Farm Clin. 1993;10:488–92. Gonzalez R, Gomez M, Monterde J. Detección “en proceso” de interacciones farmacológicas. Farm Clin. 1993;10:488–92.
37.
go back to reference Wiltink EH. Medication control in hospitals: a practical approach to the problem of drug–drug interactions. Pharm World Sci. 1998;20:173–7.PubMedCrossRef Wiltink EH. Medication control in hospitals: a practical approach to the problem of drug–drug interactions. Pharm World Sci. 1998;20:173–7.PubMedCrossRef
38.
go back to reference Gaddis GM, Holt TR, Woods M. Drug interactions in at-risk emergency department patients. Acad Emerg Med. 2002;9:1162–7.PubMedCrossRef Gaddis GM, Holt TR, Woods M. Drug interactions in at-risk emergency department patients. Acad Emerg Med. 2002;9:1162–7.PubMedCrossRef
39.
go back to reference García Batllé C, Pla Poblador R. Revisión de interacciones farmacológicas en un Hospital General. Farm Hosp. 2002;26:110–8. García Batllé C, Pla Poblador R. Revisión de interacciones farmacológicas en un Hospital General. Farm Hosp. 2002;26:110–8.
40.
go back to reference Gaeta TJ, Fiorini M, Ender K, Bove J, Diaz J. Potential drug–drug interactions in elderly patients presenting with syncope. J Emerg Med. 2002;22:159–62.PubMedCrossRef Gaeta TJ, Fiorini M, Ender K, Bove J, Diaz J. Potential drug–drug interactions in elderly patients presenting with syncope. J Emerg Med. 2002;22:159–62.PubMedCrossRef
41.
go back to reference Ledwidge M, Travers B, Ryder M, Ryan E, McDonald K. Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions. Eur J Heart Fail. 2004;6:235–43.PubMedCrossRef Ledwidge M, Travers B, Ryder M, Ryan E, McDonald K. Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions. Eur J Heart Fail. 2004;6:235–43.PubMedCrossRef
42.
go back to reference Yu DT, Peterson JF, Seger DL, Gerth WC, Bates DW. Frequency of potential azole drug–drug interactions and consequences of potential fluconazole drug interactions. Pharmacoepidemiol Drug Saf. 2005;14:755–67.PubMedCrossRef Yu DT, Peterson JF, Seger DL, Gerth WC, Bates DW. Frequency of potential azole drug–drug interactions and consequences of potential fluconazole drug interactions. Pharmacoepidemiol Drug Saf. 2005;14:755–67.PubMedCrossRef
43.
go back to reference Vonbach P, Dubied A, Beer JH, Krahenbuhl S. Recognition and management of potential drug–drug interactions in patients on internal medicine wards. Eur J Clin Pharmacol. 2007;63:1075–83.PubMedCrossRef Vonbach P, Dubied A, Beer JH, Krahenbuhl S. Recognition and management of potential drug–drug interactions in patients on internal medicine wards. Eur J Clin Pharmacol. 2007;63:1075–83.PubMedCrossRef
44.
go back to reference Martinbiancho J, Zuckermann J, Dos Santos L, Silva MM. Profile of drug interactions in hospitalized children. Pharm Pract. 2007;5:157–61. Martinbiancho J, Zuckermann J, Dos Santos L, Silva MM. Profile of drug interactions in hospitalized children. Pharm Pract. 2007;5:157–61.
45.
go back to reference Mok S, Minson Q. Drug-related problems in hospitalized patients with HIV infection. Am J Health Syst Pharm. 2008;65:55–9.PubMedCrossRef Mok S, Minson Q. Drug-related problems in hospitalized patients with HIV infection. Am J Health Syst Pharm. 2008;65:55–9.PubMedCrossRef
46.
go back to reference Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med. 1990;112:61–4.PubMed Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med. 1990;112:61–4.PubMed
47.
go back to reference Gronroos PE, Irjala KM, Huupponen RK, Scheinin H, Forsstrom J, Forsstrom JJ. A medication database—a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol. 1997;53:13–7.PubMedCrossRef Gronroos PE, Irjala KM, Huupponen RK, Scheinin H, Forsstrom J, Forsstrom JJ. A medication database—a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol. 1997;53:13–7.PubMedCrossRef
48.
go back to reference Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, Wiedermann CJ. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation. 2001;49:283–8.PubMedCrossRef Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, Wiedermann CJ. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation. 2001;49:283–8.PubMedCrossRef
49.
go back to reference Davies SJ, Eayrs S, Pratt P, Lennard MS. Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards. Br J Clin Pharmacol. 2004;57:464–72.PubMedCrossRef Davies SJ, Eayrs S, Pratt P, Lennard MS. Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards. Br J Clin Pharmacol. 2004;57:464–72.PubMedCrossRef
50.
go back to reference Samoy LJ, Zed PJ, Wilbur K, Balen RM, bu-Laban RB, Roberts M. Drugrelated hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy. 2006;26:1578–86.PubMedCrossRef Samoy LJ, Zed PJ, Wilbur K, Balen RM, bu-Laban RB, Roberts M. Drugrelated hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy. 2006;26:1578–86.PubMedCrossRef
51.
go back to reference Cruciol-Souza JM, Thomson JC. Prevalence of potential drug–drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9:427–33.PubMed Cruciol-Souza JM, Thomson JC. Prevalence of potential drug–drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9:427–33.PubMed
52.
go back to reference Jankel CA, Speedie SM. Detecting drug interactions: a review of the literature. DICP. 1990;24:982–9.PubMed Jankel CA, Speedie SM. Detecting drug interactions: a review of the literature. DICP. 1990;24:982–9.PubMed
53.
go back to reference Lalloo UG. Efavirenz and nevirapine interactions with rifampicin: resolving the dilemmas? Clin Infect Dis. 2009;48:1760–2.PubMedCrossRef Lalloo UG. Efavirenz and nevirapine interactions with rifampicin: resolving the dilemmas? Clin Infect Dis. 2009;48:1760–2.PubMedCrossRef
54.
go back to reference Soriano V, Geretti AM, Perno CF, Fätkenheuer G, Pillay D, Reynes J, et al. Optimal use of maraviroc in clinical practice. AIDS. 2008;22:2231–40.PubMedCrossRef Soriano V, Geretti AM, Perno CF, Fätkenheuer G, Pillay D, Reynes J, et al. Optimal use of maraviroc in clinical practice. AIDS. 2008;22:2231–40.PubMedCrossRef
55.
go back to reference Hellinger FJ, Encinosa WE. Inappropriate drug combinations among privately insured patients with HIV disease. Med Care. 2005;43(9 Suppl):III53–62.PubMed Hellinger FJ, Encinosa WE. Inappropriate drug combinations among privately insured patients with HIV disease. Med Care. 2005;43(9 Suppl):III53–62.PubMed
56.
go back to reference Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalizations and emergency department visits due to drug–drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16:641–51.PubMedCrossRef Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalizations and emergency department visits due to drug–drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16:641–51.PubMedCrossRef
Metadata
Title
Prevalence of drug interactions in hospital healthcare
Authors
María Espinosa-Bosch
Bernardo Santos-Ramos
María Victoria Gil-Navarro
María Dolores Santos-Rubio
Roberto Marín-Gil
Paloma Villacorta-Linaza
Publication date
01-12-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9697-0

Other articles of this Issue 6/2012

International Journal of Clinical Pharmacy 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.